You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NK/T-cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Peripheral T Cell Lymphoma Trial in Zhengzhou (SHR0302)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 2, 2023

Extranodal NK/T-cell Lymphoma Trial in Houston (sugemalimab)

Available
  • Extranodal NK/T-cell Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2022

Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
Jan 16, 2023

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
Jul 21, 2022

Early-stage, Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Beijing (Anti-PD-1 mAb)

Recruiting
  • Early-stage
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • Anti-PD-1 monoclonal antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Dec 7, 2021

Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)

Recruiting
  • Aggressive NK Cell Leukemia
  • Hiroshima, Japan
    Hiroshima University Hospital
May 9, 2023

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

Lymphoma, Extranodal NK-T-Cell Trial in Seoul (avelumab)

Active, not recruiting
  • Lymphoma, Extranodal NK-T-Cell
  • Seoul, Korea, Republic of
    81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Sep 22, 2021

Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Shanghai (Methotrexate, Etoposide, Dexamethasone)

Active, not recruiting
  • Extranodal NK/T-cell Lymphoma, Nasal Type
  • Shanghai, Shanghai, China
    Ruijin Hospital
Aug 19, 2021

Extranodal NK/T-cell Lymphoma Trial in Beijing (Gemcitabine, Pegaspargase, Etoposide)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • Beijing, China
    Beijing Tongren Hospital
Jun 2, 2021

EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,

Recruiting
  • EBV Associated Extranodal NK/T-cell Lymphoma
  • EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
  • EBViNT Cell
  • Seoul, Gangnam-gu, Korea, Republic of
  • +7 more
Jul 7, 2022

Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

Recruiting
  • Acute Myeloid Leukemia in Children
  • CIML NK Cell Infusion
  • CD3+ T Cell Product Infusion
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,

Recruiting
  • Hemophagocytic Syndrome
  • T/NK-Cell Lymphoma
  • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

Active, not recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (tislelizumab, azacytidine, lenalidomide, tislelizumab,

    Recruiting
    • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
    • tislelizumab, azacytidine, lenalidomide
    • tislelizumab, etoposide, pegaspargase
    • Shanghai, Shanghai, China
      Xinhua Hospital,Shanghai Jiao Tong University School of Medicine
    Sep 17, 2021

    Lymphoma Trial in Philadelphia (Pembrolizumab)

    Withdrawn
    • Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    May 5, 2021

    T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • +3 more
    • Universal CD7-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 17, 2023